Incyte Corp (NASDAQ:INCY)

74.03
Delayed Data
As of Jun 22
 +1.54 / +2.12%
Today’s Change
60.23
Today|||52-Week Range
140.11
-21.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.2B

Company Description

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Contact Information

Incyte Corp.
1801 Augustine Cut-Off
Wilmington Delaware 19803
P:(302) 498-6700
Investor Relations:
(302) 498-5914

Employees

Shareholders

Mutual fund holders49.71%
Other institutional45.01%
Individual stakeholders19.21%

Top Executives

Hervé HoppenotChairman, President & Chief Executive Officer
David W. GryskaChief Financial Officer & Executive Vice President
Reid M. HuberChief Scientific Officer & Executive VP
Steven H. SteinChief Medical Officer & Executive Vice President
Michael MorrisseySenior VP & Head-Global Technical Operations